NCI-MATCH Trial will Link Targeted Cancer Drugs to Gene Abnormalities

News   Jun 09, 2015

 
NCI-MATCH Trial will Link Targeted Cancer Drugs to Gene Abnormalities
 
 
 

RELATED ARTICLES

No Country for Old Genes

News

Our modern world is radically different from the one we evolved in, and that creates a mismatch between the environment our genes were evolved to face, and the world those genes now encounter. A new review looks at how certain genes that benefited humans in our genetic past now predispose us to disease in old age.

READ MORE

CRISPR Editing Stops HIV Virus in Infected Cells

News

Human immunodeficiency virus-1 (HIV-1) infection is a chronic disease affecting more than 35 million people worldwide. The infection can be controlled by antiretroviral therapy (ART), but there is still no complete cure. Now, a new study targeting the regulatory genes of the virus using CRISPR/Cas9 has helped block the production of the virus by infected cells.

READ MORE

Nanoparticles Derived from Tea Leaves Destroy Lung Cancer Cells

News

Nanoparticles derived from tea leaves inhibit the growth of lung cancer cells, destroying up to 80% of them, new research by a joint Swansea University and Indian team has shown.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE